JPS5120580B2 - - Google Patents

Info

Publication number
JPS5120580B2
JPS5120580B2 JP7037474A JP7037474A JPS5120580B2 JP S5120580 B2 JPS5120580 B2 JP S5120580B2 JP 7037474 A JP7037474 A JP 7037474A JP 7037474 A JP7037474 A JP 7037474A JP S5120580 B2 JPS5120580 B2 JP S5120580B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP7037474A
Other versions
JPS50160466A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP7037474A priority Critical patent/JPS5120580B2/ja
Publication of JPS50160466A publication Critical patent/JPS50160466A/ja
Publication of JPS5120580B2 publication Critical patent/JPS5120580B2/ja
Expired legal-status Critical Current

Links

Landscapes

  • Food-Manufacturing Devices (AREA)
JP7037474A 1974-06-19 1974-06-19 Expired JPS5120580B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7037474A JPS5120580B2 (ja) 1974-06-19 1974-06-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7037474A JPS5120580B2 (ja) 1974-06-19 1974-06-19

Publications (2)

Publication Number Publication Date
JPS50160466A JPS50160466A (ja) 1975-12-25
JPS5120580B2 true JPS5120580B2 (ja) 1976-06-25

Family

ID=13429589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7037474A Expired JPS5120580B2 (ja) 1974-06-19 1974-06-19

Country Status (1)

Country Link
JP (1) JPS5120580B2 (ja)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10611762B2 (en) 2017-05-26 2020-04-07 Incyte Corporation Crystalline forms of a FGFR inhibitor and processes for preparing the same
US10632126B2 (en) 2015-02-20 2020-04-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10738048B2 (en) 2015-02-20 2020-08-11 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10813930B2 (en) 2010-12-22 2020-10-27 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10947230B2 (en) 2013-04-19 2021-03-16 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11053246B2 (en) 2012-06-13 2021-07-06 Incyte Corporation Substituted tricyclic compounds as FGFR inhibitors
US11407750B2 (en) 2019-12-04 2022-08-09 Incyte Corporation Derivatives of an FGFR inhibitor
US11466004B2 (en) 2018-05-04 2022-10-11 Incyte Corporation Solid forms of an FGFR inhibitor and processes for preparing the same
US11607416B2 (en) 2019-10-14 2023-03-21 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10813930B2 (en) 2010-12-22 2020-10-27 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US11053246B2 (en) 2012-06-13 2021-07-06 Incyte Corporation Substituted tricyclic compounds as FGFR inhibitors
US10947230B2 (en) 2013-04-19 2021-03-16 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11530214B2 (en) 2013-04-19 2022-12-20 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US11014923B2 (en) 2015-02-20 2021-05-25 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10738048B2 (en) 2015-02-20 2020-08-11 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10632126B2 (en) 2015-02-20 2020-04-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US10611762B2 (en) 2017-05-26 2020-04-07 Incyte Corporation Crystalline forms of a FGFR inhibitor and processes for preparing the same
US11472801B2 (en) 2017-05-26 2022-10-18 Incyte Corporation Crystalline forms of a FGFR inhibitor and processes for preparing the same
US11466004B2 (en) 2018-05-04 2022-10-11 Incyte Corporation Solid forms of an FGFR inhibitor and processes for preparing the same
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
US11607416B2 (en) 2019-10-14 2023-03-21 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11407750B2 (en) 2019-12-04 2022-08-09 Incyte Corporation Derivatives of an FGFR inhibitor

Also Published As

Publication number Publication date
JPS50160466A (ja) 1975-12-25

Similar Documents

Publication Publication Date Title
FR2261236A1 (ja)
FR2296418A1 (ja)
FR2261958B1 (ja)
FR2264543B1 (ja)
IN143604B (ja)
FR2264048A1 (ja)
JPS5120580B2 (ja)
FR2286022B3 (ja)
FR2267789B1 (ja)
FR2260115B1 (ja)
FR2275238B3 (ja)
FR2282093B1 (ja)
FI753075A (ja)
AU495920B2 (ja)
AU7099174A (ja)
AU7138274A (ja)
HU170605B (ja)
CS168449B1 (ja)
BG20863A1 (ja)
CH594425A5 (ja)
AU481101A (ja)
AU481044A (ja)
AU481340A (ja)
BG19607A1 (ja)
CH584746A5 (ja)